ABcann Medicinals Inc (ABCN)

[w1104]

This part was good. What to expect in a year from now. I'm definitely holding this thing for the long term, probably adding more too if prices stay where they are for any length of time.

[–]ABcann_AMA[S] 5 points 5 days ago
Everyone is striving for similar things in this sector. Great product, high margins, low costs of goods, the best product and reputations. It's the same across the board. Our areas we like to focus on are very well known;
Standardized product that the patients can rely on, with very little variance every time they buy it. That's number one. As this will always set you apart with a specific patient population and also be readily accepted in the medical community as well as recreational. So that's the consumer level.
Our yield is obviously important also.
In a year, we want to see ABcann having the doors opened on Kimmet, Van Luven at capacity, hopefully working very closely with SYqe, and have at least two major international opportunities that are in the pipeline into full development or a major part of our revenue stream.